FOR IMMEDIATE RELEASE: March 11, 2024 [San Jose, California 03/11/24] – The Multidisciplinary Association for Psychedelic Studies (MAPS) has partnered with the City and County of Denver to provide comprehensive …
FOR IMMEDIATE RELEASE: March 07, 2024 [San Jose, California 03/07/24] – MAPS (Multidisciplinary Association for Psychedelic Studies) is excited to announce its collaboration with Texas Eclipse 2024 for …
FOR IMMEDIATE RELEASE: February 13, 2024 [San Jose, California 02/13/24] – The Multidisciplinary Association for Psychedelic Studies (MAPS) has announced that the Psychedelic Science 2025 Conference …
FOR IMMEDIATE RELEASE: February 9, 2024 The Multidisciplinary Association for Psychedelic Studies (MAPS) congratulates Lykos Therapeutics, formerly MAPS Public Benefit Corporation, on its announcement …
FOR IMMEDIATE RELEASE: January 16, 2024 The Multidisciplinary Association for Psychedelic Studies (MAPS) reintroduces itsFiscal Sponsorship Program, signaling a new era of support for grassroots organizations …
FOR IMMEDIATE RELEASE: January 5, 2024 A decade after it was founded as a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), MAPS Public Benefit Corporation (MAPS …
FOR IMMEDIATE RELEASE: December 13, 2023 MAPS Public Benefit Corporation (MAPS PBC) formally submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) which included data from …
FOR IMMEDIATE RELEASE: December 4, 2023 Yesterday’s highly anticipated football game between the San Francisco 49ers and the Philadelphia Eagles brought additional excitement to the field thanks to 49ers’ …
FOR IMMEDIATE RELEASE: November 11, 2023 In honor of Veterans Day, the Multidisciplinary Association for Psychedelic Studies (MAPS) is highlighting a series of insightful discussions focused on critical …
Many in the MAPS community are grieving the loss and suffering experienced by family, friends, colleagues, and countless others impacted by the Israel-Hamas war. At MAPS, we have been in deep dialogue …
PS2023: The Virtual Trip, produced by the Multidisciplinary Association for Psychedelic Studies (MAPS), has published an additional 40 session videos from Psychedelic Science 2023, showcasing a trove of …
FOR IMMEDIATE RELEASE: September 14, 2023 Results of the second, confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder, MAPP2, have been published in Nature Medicine. MAPP2 …
